Latest filing published 03 Jun 2009 for DAXOR CORP, €7,392.
Insider track record
No signal scores available.
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -0.8%Entry US$10.50 · Close at T+365 US$10.42
- -9.4%Entry US$16.28 · Close at T+365 US$14.75
- -7.7%Entry US$16.00 · Close at T+365 US$14.77
- -9.2%Entry US$16.25 · Close at T+365 US$14.75
- -9.2%Entry US$16.25 · Close at T+365 US$14.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin S. Wolpoff: trading record in brief
This profile gathers the share dealings of Martin S. Wolpoff in Daxor Corp. Over a trading history stretching from 17 November 2008 to 3 June 2009, the count stands at 15 filings.
In open-market terms, that means 8 purchases worth €45k on one side and 7 sales worth €37k on the other. Purchases outweigh sales by €8,084. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2009: 1 purchase and no sales on the market.
Half of the purchases are above €6,568 and half below. After 8 purchases with a full 90-day history, the hit rate stands at 13% and the median 90-day move at -2.2%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 3 June 2009 with an open-market purchase (€7,392) in Daxor Corp. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin S. Wolpoff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$10.48Daxor Common StockSEC:0001019056-09-000617:0Canonical exit: 1 Sept 2009 (T+90)
- 316 shares@ US$16.40Daxor Common StockSEC:0001019056-08-001410:0Canonical exit: 3 Mar 2009 (T+90)
- 540 shares@ US$16.40Daxor Common StockSEC:0001019056-08-001408:0Canonical exit: 2 Mar 2009 (T+90)
- 500 shares@ US$15.92Daxor Common StockSEC:0001019056-08-001395:0Canonical exit: 24 Feb 2009 (T+90)
- 100 shares@ US$15.35Daxor Common StockSEC:0001019056-08-001390:0Canonical exit: 22 Feb 2009 (T+90)
- 600 shares@ US$16.00Daxor Common StockSEC:0001019056-08-001390:1Canonical exit: 23 Feb 2009 (T+90)
- 572 shares@ US$15.90Daxor Common StockSEC:0001019056-08-001379:0Canonical exit: 19 Feb 2009 (T+90)
- 372 shares@ US$15.90Daxor Common StockSEC:0001019056-08-001360:0Canonical exit: 18 Feb 2009 (T+90)
- 1,500 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:0
- 100 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:1
- 400 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:2
- 1 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:3
- 800 shares@ US$15.25Daxor Common StockSEC:0001019056-08-001345:4
- 99 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:5
- 100 shares@ US$15.75Daxor Common StockSEC:0001019056-08-001345:6
15 of 15 declarations